Trademarkia Logo

Canada

C$
Trademark Search in Canada
BRAFTOVI (ENCORAFENIB) CAPSULES & DESIGN

View On IC.GC.CA

BRAFTOVI (ENCORAFENIB) CAPSULES & DESIGN
REGISTERED

on 30 Aug 2021

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

ARRAY BIOPHARMA INC.

3200 Walnut StreetBoulder, CO 80301

US

Serial Number

1909592 filed on 16th Jul 2018

Registration Number

TMA1107897 registered on 30th Aug 2021

Registration expiry Date

30th Aug 2031

Correspondent Address

TORYS LLP

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

BRAFTOVI (ENCORAFENIB) CAPSULES & DESIGN

Trademark usage description

pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations fo Read More

Vienna Information

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 5

Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant

24 . 17 . 25

Other signs, notations or symbolsAutres signes, notations ou symboles

Classification Information

Class [005]
Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for treating malignant tumors.

Classification kind code

11

Mark Details

Serial Number

1909592

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 12th May 2021		Advertised
Submitted for opposition 27
on 15th Apr 2021		Approval Notice Sent
Submitted for opposition 26
on 15th Apr 2021		Approved
Submitted for opposition 22
on 22nd Jul 2020		Search Recorded
Submitted for opposition 20
on 22nd Jul 2020		Examiner's First Report
Submitted for opposition 48
on 18th Feb 2020		Agent Changed
Submitted for opposition 67
on 11th Sept 2019		Agent Name Changed
Submitted for opposition 31
on 19th Jul 2018		Formalized
Submitted for opposition 1
on 17th Jul 2018		Created
Submitted for opposition 30
on 16th Jul 2018		Filed